In a significant setback for the Chicago Cubs, promising pitcher Cade Horton is confirmed to miss the entire 2026 baseball season. This unfortunate news follows the discovery of extensive damage to the ulnar collateral ligament (UCL) in his right elbow. The organization faces a challenging road ahead, as this injury further compounds existing pitching rotation issues.
Cubs' Pitching Woes Deepen as Horton Heads for Second Elbow Operation
ST. PETERSBURG, Fla. – On Tuesday, April 8, 2026, during a pre-game briefing before the Cubs’ match against the Tampa Bay Rays at Tropicana Field, Chicago manager Craig Counsell delivered the somber announcement regarding Cade Horton's season-ending injury. “Cade is going to have surgery,” Counsell stated, “He’s going to miss the rest of the year.” This confirms the fears that arose on April 3 when Horton abruptly exited a game in Cleveland after throwing only 17 pitches, visibly signaling discomfort. His fastball velocity, typically around 96 mph, had noticeably declined to 93.8 mph before his departure.
Horton, at 24 years old, is now facing his second major elbow reconstruction. He previously underwent Tommy John surgery during his freshman year at Oklahoma in 2021. Despite this prior setback, he made a remarkable recovery, becoming the seventh overall pick in the 2022 draft. Last season, Horton showcased his potential in the major leagues, achieving an impressive 11-4 record with a 2.67 ERA over 118 innings, and earning a second-place finish in the National League Rookie of the Year voting. In his 2026 debut, just a week before his injury, he limited Washington to two runs through 6 1/3 innings.
The specific surgical procedure for Horton, whether it will be a full Tommy John reconstruction or an internal brace repair, will be finalized by renowned elbow specialist Dr. Keith Meister in Arlington, Texas, following an in-depth examination. A surgery date has yet to be determined.
This latest injury is a substantial blow to the Cubs, who are already without their ace, Justin Steele, as he recovers from his own UCL surgery and is not expected to return until late May at the earliest. With Matthew Boyd also on the injured list, the team's pitching depth will be severely tested. The Cubs will now rely more heavily on pitchers like Colin Rea and Javier Assad to fill crucial roles in the rotation. Rea, who admirably stepped up last season with a 3.95 ERA over 27 starts when Steele was out, is expected to shoulder an increased workload. Counsell emphasized the collective responsibility, stating, “Colin’s going to be asked to pitch more innings out of the bullpen, and then somebody’s going to take Colin’s bullpen innings. That’s how it’s going to be addressed on paper. But it’s not all on Colin. ... We all have to just do our part.” The team faces a challenging period of adjustment as they navigate these significant pitching absences.
The recurring nature of UCL injuries in baseball, especially among young, talented pitchers like Cade Horton, highlights the immense physical demands placed on athletes at the elite level. It underscores the ongoing debate within sports medicine and coaching circles about pitcher development, workload management, and injury prevention strategies. While modern surgical techniques offer hope for recovery, each such injury represents a profound personal and professional challenge for the athlete and a strategic dilemma for their team. It serves as a stark reminder of the fragility of athletic careers and the constant battle against the physical tolls of professional sports.
